We aim to reduce disparities in cancer outcomes among marginalized local communities and become a national model for translating disparities research into clinical interventions.
Established in January 2012, the Cancer Care Equity Program (CCEP) aims to place Dana-Farber Cancer Institute at the forefront of efforts to reduce disparities in cancer outcomes for historically marginalized groups locally, in the Greater Boston area, as well as become a national model for translating cancer equity research into interventions.
The Role of the CCEP Is to
- Facilitate clinical access to Dana-Farber’s spectrum of preventive medicine, treatment, and clinical trials
- Partner with Community Benefits Office to enhance and expand Dana-Farber’s community outreach and educational programs
- Initiate and unite cancer equity research across Dana-Farber
Through these efforts, the CCEP broadens access to historically marginalized patient populations and joins our community partners in the pursuit of equitable care across the spectrum of cancer-related disease.
